title: Updates in the treatment of multiple myeloma.
authors.affiliation: Oncotherapeutics, West Hollywood, California, USA.
authors.forename: James R
authors.initials: JR
authors.lastname: Berenson
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D053301:B-Cell Maturation Antigen / Q000097:blood / Q000276:immunology; D015415:Biomarkers / Q000097:blood; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001842:Bone and Bones / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D004164:Diphosphonates / Q000627:therapeutic use*; D019468:Disease Management; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D009101:Multiple Myeloma / Q000276:immunology / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D061988:Proteasome Inhibitors / Q000627:therapeutic use*; D011788:Quality of Life; D012008:Recurrence; D016019:Survival Analysis; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D000077211:Zoledronic Acid
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D053301:B-Cell Maturation Antigen; D015415:Biomarkers; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D061988:Proteasome Inhibitors; C086966:TNFRSF17 protein, human; D000077211:Zoledronic Acid